Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib

Overview of attention for article published in Frontiers in Pharmacology, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 5 news stories from 5 outlets.

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits…

The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS…

The anti-cancer drug abemaciclib (also known as Vernezio) has this month to the Australian Pharmaceutical Benefits Scheme (PBS…

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 1 additional news stories.